Сингапур - Енглески - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - estradiol (as hemihydrate) micronized; norethisterone acetate micronized - tablet, film coated - 1 mg - estradiol (as hemihydrate) micronized 1 mg; norethisterone acetate micronized 0.5 mg

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

galen ltd - norethisterone acetate; ethinylestradiol - oral tablet - 1mg ; 20microgram

Белгија - Енглески - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novo nordisk pharma sa-nv - estradiol hemihydrate 1,03 mg - eq. estradiol 1 mg (white tablet); norethisterone acetate 1 mg (white tablet); estradiol hemihydrate 1,03 mg - eq. estradiol 1 mg (red tablet) - film-coated tablet - 1 mg + 1 mg - 1 mg - estradiol hemihydrate 1.03 mg; estradiol hemihydrate 1.03 mg; norethisterone acetate 1 mg - norethisterone and estrogen

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - estradiol anhydrous; norethisterone acetate - film-coated tablet - 1 mg / 0.5 milligram(s) - progestogens and estrogens, fixed combinations; norethisterone and estrogen

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %);  ;  ;  ; norethisterone acetate 1mg;  ;  ;  ; estradiol hemihydrate 1.03mg (adjustment for water content 3.2%); estradiol hemihydrate 2.07mg (adjustment for water content 3.2%); estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %); estradiol hemihydrate 1.03mg (adjustment for water content 3.2 %); estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %); norethisterone acetate 1mg - film coated tablet - active: estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %)       norethisterone acetate 1mg       excipient: hyprolose hypromellose lactose monohydrate magnesium stearate maize starch purified talc purified water triacetin active: estradiol hemihydrate 1.03mg (adjustment for water content 3.2%) excipient: hyprolose hypromellose iron oxide red as red paste, with titanium dioxide, hypromellose, talc and propylene glycol lactose monohydrate magnesium stearate maize starch propylene glycol purified talc   purified water titanium dioxide active: estradiol hemihydrate 2.07mg (adjustment for water content 3.2%) excipient: hyprolose hypromellose indigo carmine lactose monohydrate macrogol 400 magnesium stearate maize starch purified talc   purified water titanium dioxide active: estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %) estradiol hemihydrate 1.03mg (adjustment for water content 3.2 %) estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %) norethisterone acetate 1mg - trisequens is indicated for the treatment of oestrogen deficiency syndrome, including prevention of bone mineral content loss in postmenopausal women at increased risk of developing fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis (see also warnings and precautions)

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %);  ;  ;  ; norethisterone acetate 1mg;  ;  ;  ; estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %); norethisterone acetate 1mg - film coated tablet - active: estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %)       norethisterone acetate 1mg       excipient: hyprolose hypromellose lactose monohydrate magnesium stearate maize starch purified talc purified water triacetin active: estradiol hemihydrate 2.07mg (adjustment for water content 3.2 %) norethisterone acetate 1mg

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - estradiol hemihydrate 1.55mg equivalent to estradiol 1.5 mg;  ; nomegestrol acetate 2.5mg;  ;   - tablet - 2.5mg/1.5mg - active: estradiol hemihydrate 1.55mg equivalent to estradiol 1.5 mg   nomegestrol acetate 2.5mg     excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 85f18422 purified talc colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f32865 purified talc - oral contraception

Израел - Енглески - Ministry of Health

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone as acetate - film coated tablets - estradiol as hemihydrate 1 mg; norethisterone as acetate 0.5 mg - norethisterone and estrogen - norethisterone and estrogen - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in women more than one year after menopause. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of , or contraindicated for, other medicinal products approved for the prevention of osteoporosis. the experience treating women older than 65 years is limited.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

kaiser foundation hospitals - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.5 mg - estradiol tablets usp are indicated in the: - treatment of moderate to severe vasomotor symptoms associated with the menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. - treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. - treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). - prevention of osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate. (see clinical pharmacology , clinical studies .) the mainstays for decreasing the risk of postmenop

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 1 mg - estradiol tablets usp are indicated in the: estrogens should not be used in individuals with any of the following conditions: